Founded in December 2021, Alcanza Clinical Research was started by Martis as a leading clinical research site network providing high quality execution and removing barriers to increase patient accessibility for clinical trials. The Company provides full-scale Phase I-IV capabilities across multiple therapeutic areas and maintains a diverse client base of blue-chip pharma sponsors and CROs.
Investment Rationale
Strong market tailwinds in pharma services outsourcing with recession resilient dynamics
Significant benefits of scale and opportunity for consolidation
Opportunity to implement platform-wide operational best practices
Enter the username or e-mail you used in your profile. A password reset link will be sent to you by email.
Our website uses cookies to give you the best online experience. By using our website, you agree to our use of cookies. For more information, please review our Privacy Policy.
